Results 81 to 90 of about 2,105 (253)
Solvability of a close to symmetric system of difference equations
Summary: The problem of solvability of a close to symmetric product-type system of difference equations of second order is investigated. Some recent results in the literature are extended.
Stevič, Stevo +2 more
openaire +3 more sources
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
A new class of solvable nonlinear difference equation systems
The paper deals with the following system of nonlinear difference equations \begin{equation*} x_{n+1}=ax_{n}^{2}y_{n}+bx_{n}y_{n}^{2},\ y_{n+1}=cx_{n}^{2}y_{n}+dx_{n}y_{n}^{2},\ n\in \mathbb{N}_{0}, \end{equation*} where the initial values $x_{0},y_{0}$ and the parameters $a$, $b$, $c$, $d$ are arbitrary real numbers, which is a new class of solvable ...
openaire +2 more sources
Finding novel vulnerabilities of hypomorphic BRCA1 alleles
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder +10 more
wiley +1 more source
Global behavior of a third order rational difference equation [PDF]
summary:In this paper, we determine the forbidden set and give an explicit formula for the solutions of the difference equation $$x_{n+1}=\frac {ax_{n}x_{n-1}}{-bx_{n}+ cx_{n-2}},\quad n\in \mathbb {N}_0 $$ where $a$, $b$, $c$ are positive real numbers ...
Aloqeili, Marwan, Abo-Zeid, Raafat
core +1 more source
On a solvable symmetric and a cyclic system of partial difference equations
It is shown that the following symmetric system of partial difference equations cm,n = dm-1,n + cm-1, n-1, dm,n = cm-1,n + dm-1,n-1, is solvable on the combinatorial domain C = n {(m,n) ? N20 : 0 ? n ? m}\{(0,0)}, by presenting some formulas for the general solution to the system on the domain in terms of the boundary values cj,j, cj,0, dj,j ...
Stević, Stevo +2 more
openaire +3 more sources
MITF maintains genome stability in nonmelanocyte lineages
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
Solvability of a class of product-type systems of difference equations [PDF]
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire +1 more source
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source

